RESEARCH GUIDE / PUBLISHED
Reading a certificate of analysis
A COA is a batch-linked laboratory report. Learn what identity, purity, concentration, methods, provenance, sterility, and endotoxin results do—and do not—establish.
First, link the document to the batch
For active pharmaceutical ingredients within ICH Q7's scope, a certificate of analysis should identify the material and batch, list each required test with its acceptance limit and numerical result, and identify the responsible manufacturer or laboratory. The batch identifier on any document still needs a traceable relationship to the labelled container and to the sample the laboratory actually received.
A polished PDF is not chain of custody. Ask who selected and submitted the sample, whether the laboratory sampled it independently, whether seals and receipt condition were recorded, and whether the report can be verified with the issuing laboratory. A result for one sample does not automatically cover every container or later batch.
Section sources: FDA/ICH Q7: Good Manufacturing Practice Guidance for Active Pharmaceutical Ingredients; NIST metrological traceability policy and FAQ
Identity, purity, and concentration are different claims
Identity asks what substance produced the measured pattern. Purity estimates how much of a measured sample is assigned to the main component relative to detected impurities under a stated method. Concentration describes an amount in a mass or volume. One number cannot silently answer all three questions.
Chromatographic purity by area percentage, for example, depends on separation, detector response, integration, reference materials, and which impurities the method can see. It does not necessarily equal mass fraction or confirm the amount in a vial. Orthogonal methods can test different properties and strengthen an identity assignment.
Section sources: FDA: Analytical Procedures and Methods Validation for Drugs and Biologics
Read the method, specification, and units
A result is interpretable only with the method and acceptance criterion. Look for the instrument or compendial procedure, reference standard, sample preparation, calibration, system-suitability result, detection or quantitation limits where relevant, and the reporting basis. ‘Pass’ without the underlying specification and result is thin evidence.
FDA analytical-method guidance emphasizes specificity, accuracy, precision, range, and the intended use of the procedure. Method suitability is matrix-specific: a procedure that works for a clean reference solution may not perform the same way with a formulated or degraded sample.
Section sources: FDA: Analytical Procedures and Methods Validation for Drugs and Biologics
Laboratory provenance and traceability matter
Record the legal laboratory name, location, report or verification identifier, accreditation scope where claimed, analyst and reviewer sign-off practices, and whether the laboratory developed or merely ran the method. Accreditation is relevant only to its scope and does not make every conclusion correct.
NIST describes measurement traceability as a documented chain to stated references with uncertainty. A certified reference material carries values for specified properties, intended use, uncertainty, and traceability; using one does not automatically make every later measurement traceable. Preppy Boy's shorthand: ‘Show me the chain, not just the logo.’
Section sources: NIST reference materials; NIST metrological traceability policy and FAQ
Sterility and endotoxin are separate questions
A chemical identity or purity test does not establish sterility. A sterility result and a bacterial endotoxin result address different hazards through different procedures. If either claim matters, the report should identify the sample, validated method, acceptance criterion, result, controls, and relevant handling conditions for that test.
FDA's current endotoxin guidance notes that method suitability, interference, storage, handling, and predefined procedures affect interpretation. A result below a limit is not a universal declaration that a material is pyrogen-free, and an endotoxin test is not a sterility test.
Section sources: FDA: Pyrogen and Endotoxins Testing—Questions and Answers, Edition 2; FDA CGMP questions and answers: production and process controls
What a COA cannot establish
A COA cannot establish a therapeutic benefit, safe route, appropriate dose, regulatory approval, or suitability for a particular person. It cannot repair a broken batch link, prove untested properties, or guarantee that every unit matches the submitted sample. Results are bounded by sampling, method, uncertainty, detection capability, and the report's authenticity.
Captain Peptide may celebrate a well-designed identity result. Preppy Boy still asks about sampling, method limits, batch linkage, and every claim that was not tested. The right conclusion is specific: this laboratory reported this result for this sample using this method on this date.
Section sources: FDA: Analytical Procedures and Methods Validation for Drugs and Biologics; NIST metrological traceability policy and FAQ; FDA: Pyrogen and Endotoxins Testing—Questions and Answers, Edition 2
A compact COA checklist
Match the product and batch identifiers. Verify the issuer and report identifier. Separate each tested attribute. Read numeric results beside units and specifications. Inspect methods, reference standards, controls, dates, signatures, and amendments. Note missing tests explicitly rather than converting absence into a pass.
Finally, write the narrow claim the document supports and the decisions it cannot support. Captain Peptide does not currently publish batch COAs; this guide is education for evaluating future documents, not a quality claim about catalogue materials.
Section sources: FDA: Analytical Procedures and Methods Validation for Drugs and Biologics; NIST reference materials
